{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T15:09:57Z","timestamp":1763996997189,"version":"3.45.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,11,24]]},"DOI":"10.7759\/cureus.97654","type":"journal-article","created":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T15:05:02Z","timestamp":1763996702000},"source":"Crossref","is-referenced-by-count":0,"title":["Beyond Traditional Risk Factors: Inflammation, Asymmetric Dimethylarginine, and N-Terminal pro\u2013B-Type Natriuretic Peptide Predict Cardiovascular Risk in Chronic Kidney Disease"],"prefix":"10.7759","author":[{"given":"Eneida","family":"Hoxha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ledio","family":"Collaku","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Somida","family":"Kuka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saimir","family":"Seferi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pandush","family":"Pojani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xhesika","family":"Habilaj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matilda","family":"Kambo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizana","family":"Zaimi (Petrela)","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anyla","family":"Bulo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margarita","family":"Resuli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.kisu.2021.11.003","article-title":"Epidemiology of chronic kidney disease: an update 2022","volume":"12","author":"Kovesdy CP","year":"2022","unstructured":"Kovesdy CP. Epidemiology of chronic kidney disease: an update 2022. Kidney Int Suppl (2011). 2022, 12:7-11. 10.1016\/j.kisu.2021.11.003","journal-title":"Kidney Int Suppl (2011)"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)60595-4","article-title":"Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention","volume":"382","author":"Gansevoort RT","year":"2013","unstructured":"Gansevoort RT, Correa-Rotter R, Hemmelgarn BR, et al.. Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention. Lancet. 2013, 382:339-52. 10.1016\/S0140-6736(13)60595-4","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.120.050686","article-title":"Cardiovascular disease in chronic kidney disease: pathophysiological insights and therapeutic options","volume":"143","author":"Jankowski J","year":"2021","unstructured":"Jankowski J, Floege J, Fliser D, B\u00f6hm M, Marx N. Cardiovascular disease in chronic kidney disease: pathophysiological insights and therapeutic options. Circulation. 2021, 143:1157-72. 10.1161\/CIRCULATIONAHA.120.050686","journal-title":"Circulation"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0192895","article-title":"Cardiovascular disease risk factors in chronic kidney disease: a systematic review and meta-analysis","volume":"13","author":"Major RW","year":"2018","unstructured":"Major RW, Cheng MR, Grant RA, et al.. Cardiovascular disease risk factors in chronic kidney disease: a systematic review and meta-analysis. PLoS One. 2018, 13:e0192895. 10.1371\/journal.pone.0192895","journal-title":"PLoS One"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.107.699579","article-title":"General cardiovascular risk profile for use in primary care: the Framingham Heart Study","volume":"117","author":"D'Agostino RB Sr","year":"2008","unstructured":"D'Agostino RB Sr, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, Kannel WB. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation. 2008, 117:743-53. 10.1161\/CIRCULATIONAHA.107.699579","journal-title":"Circulation"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3390\/jpm12071180","article-title":"Cardiovascular risk prediction models and scores in the era of personalized medicine","volume":"12","author":"Sofogianni A","year":"2022","unstructured":"Sofogianni A, Stalikas N, Antza C, Tziomalos K. Cardiovascular risk prediction models and scores in the era of personalized medicine. J Pers Med. 2022, 12:10.3390\/jpm12071180","journal-title":"J Pers Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfac199","article-title":"Chronic kidney disease as cardiovascular risk factor in routine clinical practice: a position statement by the Council of the European Renal Association","volume":"16","author":"Ortiz A","year":"2023","unstructured":"Ortiz A, Wanner C, Gansevoort R. Chronic kidney disease as cardiovascular risk factor in routine clinical practice: a position statement by the Council of the European Renal Association. Clin Kidney J. 2023, 16:403-7. 10.1093\/ckj\/sfac199","journal-title":"Clin Kidney J"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2018.09.012","article-title":"Use of measures of inflammation and kidney function for prediction of atherosclerotic vascular disease events and death in patients with CKD: findings from the CRIC study","volume":"73","author":"Amdur RL","year":"2019","unstructured":"Amdur RL, Feldman HI, Dominic EA, et al.. Use of measures of inflammation and kidney function for prediction of atherosclerotic vascular disease events and death in patients with CKD: findings from the CRIC study. Am J Kidney Dis. 2019, 73:344-53. 10.1053\/j.ajkd.2018.09.012","journal-title":"Am J Kidney Dis"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20153668","article-title":"Asymmetric (ADMA) and symmetric (SDMA) dimethylarginines in chronic kidney disease: a clinical approach","volume":"20","author":"Oliva-Damaso E","year":"2019","unstructured":"Oliva-Damaso E, Oliva-Damaso N, Rodriguez-Esparragon F, et al.. Asymmetric (ADMA) and symmetric (SDMA) dimethylarginines in chronic kidney disease: a clinical approach. Int J Mol Sci. 2019, 20:10.3390\/ijms20153668","journal-title":"Int J Mol Sci"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchf.2024.08.009","article-title":"Natriuretic peptides, kidney function, and clinical outcomes in heart failure with preserved ejection fraction","volume":"13","author":"Neuen BL","year":"2025","unstructured":"Neuen BL, Vaduganathan M, Claggett BL, et al.. Natriuretic peptides, kidney function, and clinical outcomes in heart failure with preserved ejection fraction. JACC Heart Fail. 2025, 13:28-39. 10.1016\/j.jchf.2024.08.009","journal-title":"JACC Heart Fail"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.51362","article-title":"Navigating the crossroads: understanding the link between chronic kidney disease and cardiovascular health","volume":"15","author":"Saeed D","year":"2023","unstructured":"Saeed D, Reza T, Shahzad MW, et al.. Navigating the crossroads: understanding the link between chronic kidney disease and cardiovascular health. Cureus. 2023, 15:e51362. 10.7759\/cureus.51362","journal-title":"Cureus"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2023.05.014","article-title":"Associations of N-terminal pro-B-type natriuretic peptide, estimated glomerular filtration rate, and mortality in US adults","volume":"264","author":"Ozkan B","year":"2023","unstructured":"Ozkan B, Grams ME, Coresh J, et al.. Associations of N-terminal pro-B-type natriuretic peptide, estimated glomerular filtration rate, and mortality in US adults. Am Heart J. 2023, 264:49-58. 10.1016\/j.ahj.2023.05.014","journal-title":"Am Heart J"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines9040404","article-title":"Vascular calcification in chronic kidney disease: diversity in the vessel wall","volume":"9","author":"Dube P","year":"2021","unstructured":"Dube P, DeRiso A, Patel M, et al.. Vascular calcification in chronic kidney disease: diversity in the vessel wall. Biomedicines. 2021, 9:404. 10.3390\/biomedicines9040404","journal-title":"Biomedicines"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1159\/000542628","article-title":"A new clinical entity bridging the cardiovascular system and the kidney: the chronic cardiovascular-kidney disorder","volume":"15","author":"Zoccali C","year":"2025","unstructured":"Zoccali C. A new clinical entity bridging the cardiovascular system and the kidney: the chronic cardiovascular-kidney disorder. Cardiorenal Med. 2025, 15:21-8. 10.1159\/000542628","journal-title":"Cardiorenal Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey AS","year":"2009","unstructured":"Levey AS, Stevens LA, Schmid CH, et al.. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009, 150:604-12. 10.7326\/0003-4819-150-9-200905050-00006","journal-title":"Ann Intern Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.echo.2014.10.003","article-title":"Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"28","author":"Lang RM","year":"2015","unstructured":"Lang RM, Badano LP, Mor-Avi V, et al.. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2015, 28:1-39.e14. 10.1016\/j.echo.2014.10.003","journal-title":"J Am Soc Echocardiogr"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvad083","article-title":"Cardiovascular complications in chronic kidney disease: a review from the European Renal and Cardiovascular Medicine Working Group of the European Renal Association","volume":"119","author":"Zoccali C","year":"2023","unstructured":"Zoccali C, Mallamaci F, Adamczak M, et al.. Cardiovascular complications in chronic kidney disease: a review from the European Renal and Cardiovascular Medicine Working Group of the European Renal Association. Cardiovasc Res. 2023, 119:2017-32. 10.1093\/cvr\/cvad083","journal-title":"Cardiovasc Res"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000001184","article-title":"Cardiovascular-kidney-metabolic health: a presidential advisory from the American Heart Association","volume":"148","author":"Ndumele CE","year":"2023","unstructured":"Ndumele CE, Rangaswami J, Chow SL, et al.. Cardiovascular-kidney-metabolic health: a presidential advisory from the American Heart Association. Circulation. 2023, 148:1606-35. 10.1161\/CIR.0000000000001184","journal-title":"Circulation"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1007\/s00011-023-01845-6","article-title":"Inflammation in heart failure: pathophysiology and therapeutic strategies","volume":"73","author":"Boulet J","year":"2024","unstructured":"Boulet J, Sridhar VS, Bouabdallaoui N, Tardif JC, White M. Inflammation in heart failure: pathophysiology and therapeutic strategies. Inflamm Res. 2024, 73:709-23. 10.1007\/s00011-023-01845-6","journal-title":"Inflamm Res"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.122.321749","article-title":"Innate immunity system in patients with cardiovascular and kidney disease","volume":"132","author":"Zoccali C","year":"2023","unstructured":"Zoccali C, Mallamaci F. Innate immunity system in patients with cardiovascular and kidney disease. Circ Res. 2023, 132:915-32. 10.1161\/CIRCRESAHA.122.321749","journal-title":"Circ Res"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfx379","article-title":"New insights into the key role of interleukin 6 in vascular calcification of chronic kidney disease","volume":"33","author":"H\u00e9naut L","year":"2018","unstructured":"H\u00e9naut L, Massy ZA. New insights into the key role of interleukin 6 in vascular calcification of chronic kidney disease. Nephrol Dial Transplant. 2018, 33:543-8. 10.1093\/ndt\/gfx379","journal-title":"Nephrol Dial Transplant"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9082359","article-title":"Endothelial dysfunction in chronic kidney disease, from biology to clinical outcomes: a 2020 update","volume":"9","author":"Roumeliotis S","year":"2020","unstructured":"Roumeliotis S, Mallamaci F, Zoccali C. Endothelial dysfunction in chronic kidney disease, from biology to clinical outcomes: a 2020 update. J Clin Med. 2020, 9:2359. 10.3390\/jcm9082359","journal-title":"J Clin Med"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14041051","article-title":"Asymmetric dimethylarginine (ADMA) as a novel risk factor for progression of coronary artery calcification in patients with chronic kidney disease","volume":"14","author":"Kobayashi S","year":"2025","unstructured":"Kobayashi S, Ohtake T, Mochida Y, et al.. Asymmetric dimethylarginine (ADMA) as a novel risk factor for progression of coronary artery calcification in patients with chronic kidney disease. J Clin Med. 2025, 14:1051. 10.3390\/jcm14041051","journal-title":"J Clin Med"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26136298","article-title":"Homocysteine attack on vascular endothelium\u2014old and new features","volume":"26","author":"Hurjui LL","year":"2025","unstructured":"Hurjui LL, Tarniceriu CC, Serban DN, et al.. Homocysteine attack on vascular endothelium\u2014old and new features. Int J Mol Sci. 2025, 26:6298. 10.3390\/ijms26136298","journal-title":"Int J Mol Sci"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfae421","article-title":"Valvular calcification in chronic kidney disease: new insights from recent clinical and preclinical studies","volume":"18","author":"H\u00e9naut L","year":"2025","unstructured":"H\u00e9naut L, Candellier A, Huish S, Issa N, Sinha S, Massy ZA. Valvular calcification in chronic kidney disease: new insights from recent clinical and preclinical studies. Clin Kidney J. 2025, 18:i27-45. 10.1093\/ckj\/sfae421","journal-title":"Clin Kidney J"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2025.07.028","article-title":"Crystal clear - part I: the role of uric acid in cardiorenal disease","author":"Borghi C","year":"2025","unstructured":"Borghi C, Fogacci F, Cicero AF. Crystal clear - part I: the role of uric acid in cardiorenal disease. Eur J Intern Med. 2025, 10.1016\/j.ejim.2025.07.028","journal-title":"Eur J Intern Med"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9072027","article-title":"The complex relationship between serum uric acid, endothelial function and small vessel remodeling in humans","volume":"9","author":"Masi S","year":"2020","unstructured":"Masi S, Georgiopoulos G, Alexopoulos G, et al.. The complex relationship between serum uric acid, endothelial function and small vessel remodeling in humans. J Clin Med. 2020, 9:2027. 10.3390\/jcm9072027","journal-title":"J Clin Med"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-026030","article-title":"Plasma NT-proBNP levels associated with cardiac structural abnormalities in asymptomatic health examinees with preserved ejection fraction: a retrospective cross-sectional study","volume":"9","author":"Nah EH","year":"2019","unstructured":"Nah EH, Kim SY, Cho S, Kim S, Cho HI. Plasma NT-proBNP levels associated with cardiac structural abnormalities in asymptomatic health examinees with preserved ejection fraction: a retrospective cross-sectional study. BMJ Open. 2019, 9:e026030. 10.1136\/bmjopen-2018-026030","journal-title":"BMJ Open"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.115.001833","article-title":"Asymmetric dimethylarginine and cardiovascular risk: systematic review and meta-analysis of 22 prospective studies","volume":"4","author":"Willeit P","year":"2015","unstructured":"Willeit P, Freitag DF, Laukkanen JA, et al.. Asymmetric dimethylarginine and cardiovascular risk: systematic review and meta-analysis of 22 prospective studies. J Am Heart Assoc. 2015, 4:e001833. 10.1161\/JAHA.115.001833","journal-title":"J Am Heart Assoc"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.3390\/cells12121581","article-title":"The role of inflammation in CKD","volume":"12","author":"Kadatane SP","year":"2023","unstructured":"Kadatane SP, Satariano M, Massey M, Mongan K, Raina R. The role of inflammation in CKD. Cells. 2023, 12:1581. 10.3390\/cells12121581","journal-title":"Cells"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/424780-beyond-traditional-risk-factors-inflammation-asymmetric-dimethylarginine-and-n-terminal-pro-b-type-natriuretic-peptide-predict-cardiovascular-risk-in-chronic-kidney-disease","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T15:05:03Z","timestamp":1763996703000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/424780-beyond-traditional-risk-factors-inflammation-asymmetric-dimethylarginine-and-n-terminal-pro-b-type-natriuretic-peptide-predict-cardiovascular-risk-in-chronic-kidney-disease"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,24]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.97654","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11,24]]}}}